Literature DB >> 15454249

French version of FACT-G: validation and comparison with other cancer-specific instruments.

T Conroy1, M Mercier, J Bonneterre, E Luporsi, J L Lefebvre, M Lapeyre, M Puyraveau, S Schraub.   

Abstract

The aim of this study was to assess the validity of the French version of the Functional Assessment of Cancer Therapy - General (FACT-G), and to compare its psychometric properties with those of two other cancer-specific quality of life questionnaires, European Organisation for Research and Treatment of Cancer Quality of Life - Core 30 (EORTC QLQ-C30) and Functional Living Index - Cancer (FLIC). Two hundred and twenty three patients with breast or colorectal cancer completed the FACT-G questionnaire in French followed by (in random order) the QLQ-C30 and FLIC. An additional 87 patients with head and neck (H&N) cancer completed the FACT-H&N followed by the QLQ-C30 and H&N-Besançon. The French version of FACT-G was internally consistent, and its reproducibility was excellent. FACT-G Physical Well-Being and global scores correlated with all QLQ-C30 subscales. There was evidence of discriminant validity. Compared with the other tools, FACT-G included a statistically significantly higher proportion of items patients considered to be confusing or upsetting. Patients with breast or colorectal cancer expressed a preference for QLQ-C30. Use of the specific H&N additional items increased the responsiveness to change of FACT-G. The French version of FACT-G is valid and has psychometric properties similar to those of FLIC and QLQ-C30.

Entities:  

Mesh:

Year:  2004        PMID: 15454249     DOI: 10.1016/j.ejca.2004.06.010

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  26 in total

1.  Quality of life and coping of women treated for breast cancer and their caregiver. What are the interactions?

Authors:  Angélique Bonnaud-Antignac; Jean-Benoit Hardouin; Julie Leger; François Dravet; Véronique Sebille
Journal:  J Clin Psychol Med Settings       Date:  2012-09

2.  Validation of the FACT-G scale for evaluating quality of life in cancer patients in Colombia.

Authors:  Ricardo Sánchez; Monica Ballesteros; Benjamin J Arnold
Journal:  Qual Life Res       Date:  2010-10-30       Impact factor: 4.147

3.  Health-related quality of life 18 months after breast cancer: comparison with the general population of Queensland, Australia.

Authors:  Tracey DiSipio; Sandi Hayes; Beth Newman; Monika Janda
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

Review 4.  Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.

Authors:  David Victorson; Joshua Barocas; Juliette Song; David Cella
Journal:  Qual Life Res       Date:  2008-10-08       Impact factor: 4.147

5.  Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.

Authors:  Cécile Barbaret; Marvin O Delgado-Guay; Stéphane Sanchez; Christelle Brosse; Murielle Ruer; Wadih Rhondali; Léa Monsarrat; Patrick Michaud; Anne Marie Schott; Eduardo Bruera; Marilène Filbet
Journal:  Oncologist       Date:  2019-03-15

6.  Home parenteral nutrition improves quality of life and nutritional status in patients with cancer: a French observational multicentre study.

Authors:  S Culine; C Chambrier; A Tadmouri; P Senesse; P Seys; A Radji; M Rotarski; A Balian; P Dufour
Journal:  Support Care Cancer       Date:  2014-02-21       Impact factor: 3.603

7.  Patient reported outcomes in head and neck cancer: selecting instruments for quality of life integration in clinical protocols.

Authors:  Augusta P Silveira; Joaquim Gonçalves; Teresa Sequeira; Cláudia Ribeiro; Carlos Lopes; Eurico Monteiro; Francisco L Pimentel
Journal:  Head Neck Oncol       Date:  2010-10-31

8.  Validation of the French version of the colorectal-specific quality-of-life questionnaires EORTC QLQ-CR38 and FACT-C.

Authors:  Christine Rotonda; T Conroy; M Mercier; F Bonnetain; L Uwer; J Miny; P Montcuquet; I Léonard; A Adenis; G Breysacher; F Guillemin
Journal:  Qual Life Res       Date:  2008-03-13       Impact factor: 4.147

Review 9.  The impact of clinical and sociodemographic features on quality of life in patients with early stage cancers using the Functional Assessment of Cancer Therapy-General assessment tool.

Authors:  Marko Popovic; Nicholas Lao; Liang Zeng; Liying Zhang; David Cella; Jennifer L Beaumont; Ronald Chow; Nicholas Chiu; Leonard Chiu; Henry Lam; Michael Poon; Edward Chow
Journal:  Support Care Cancer       Date:  2013-03-22       Impact factor: 3.603

10.  Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.

Authors:  T Conroy; M Hebbar; J Bennouna; M Ducreux; M Ychou; G Llédo; A Adenis; R Faroux; C Rebischung; L Kockler; J Y Douillard
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.